Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-2.45, missing the consensus estimate of $-2.29 by $0.16 per share. Revenue came in at , meeting the estimate of .
Aethlon Medical's stock moved following the earnings release. The stock currently trades at $1.92 with a market capitalization of $2.6M.